CRNX - Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01 revenue of $0.71M beats by $0.41M
- Crinetics Pharmaceuticals press release ( NASDAQ: CRNX ): Q4 GAAP EPS of -$0.84 misses by $0.01 .
- Revenue of $0.71M (-34.3% Y/Y) beats by $0.41M .
- Unrestricted cash, cash equivalents, and investments totaled $334.4 million as of December 31, 2022, compared to $368.4 million as of September 30, 2022, and $333.7 million as of December 31, 2021.
For further details see:
Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M